[ Price : $8.95]
Researchers in China say they found several new adverse event signals in their review of 20 years of FDA adverse event reports on ...[ Price : $8.95]
The Department of Justice has requested information from Inspire Medical as part of a civil probe into its marketing, promotion, a...[ Price : $8.95]
FDA clarifies its enforcement discretion timeframes for compounded tirzepatide.[ Price : $8.95]
FDA approves a Genentech NDA for a new tablet formulation of Evrysdi (risdiplam) for treating people with spinal muscular atrophy.[ Price : $8.95]
Travere Therapeutics says it will submit an sNDA to FDA for a new indication for its Filspari to treat focal segmental glomerulosc...[ Price : $8.95]
FDA approves a Pfizer supplemental BLA for Adcetris (brentuximab vedotin) in combination with lenalidomide and rituximab for treat...[ Price : $8.95]
FDA warns Healdsburg, CA-based ISOThrive about failing to submit an IND for two clinical trials it sponsored of an investigational...[ Price : $8.95]
FDA warns Chinas Wuhu Chemistry about CGMP deviations in its manufacturing of active pharmaceutical ingredients.